Met Life Investment Management, LLC Ocugen, Inc. Transaction History
Met Life Investment Management, LLC
- $17.1 Billion
- Q3 2024
A detailed history of Met Life Investment Management, LLC transactions in Ocugen, Inc. stock. As of the latest transaction made, Met Life Investment Management, LLC holds 89,508 shares of OCGN stock, worth $84,137. This represents 0.0% of its overall portfolio holdings.
Number of Shares
89,508
Previous 65,631
36.38%
Holding current value
$84,137
Previous $101,000
12.87%
% of portfolio
0.0%
Previous 0.0%
Shares
29 transactions
Others Institutions Holding OCGN
# of Institutions
125Shares Held
78.3MCall Options Held
535KPut Options Held
523K-
Black Rock Inc. New York, NY17.9MShares$16.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA16.9MShares$15.9 Million0.0% of portfolio
-
State Street Corp Boston, MA15.8MShares$14.9 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA6.28MShares$5.9 Million0.0% of portfolio
-
Gmt Capital Corp Atlanta, GA2.45MShares$2.31 Million0.1% of portfolio
About Ocugen, Inc.
- Ticker OCGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 216,566,000
- Market Cap $204M
- Description
- Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmento...